Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- The blood-brain barrier
- Blood-brain Barrier – discovery
- Capillaries of the blood-brain barrier
- Neurovascular unit - anatomy
- Neurovascular unit - function
- Alzheimer’s disease
- Alzheimer’s disease – discovery
- Alzheimer’s disease – numbers and facts
- Healthy brain vs. AD's brain
- Alzheimer’s disease – A-beta plaques
- Alzheimer’s disease – pathology
- Diagnosis, prognosis and treatment
- The blood-brain barrier in Alzheimer’s disease
- The blood-brain barrier in AD - 4 key changes
- The vascular hypothesis
- Cerebral blood flow - vessel deformation and distortion
- Cerebral blood flow
- The blood-brain barrier in AD - glucose transport
- Glucose transport – fuel for the brain
- Glucose transport - alternate fuels
- Glucose transport
- The blood-brain barrier in AD - A-beta clearance
- A-beta clearance
- A-beta clearance - A-beta40
- A-beta transport mechanism
- A-beta clearance - current knowledge
- The blood-brain barrier in AD - barrier leakage
- Blood-brain barrier leakage in CAA
- Blood-brain barrier leakage - published data
- Blood-brain barrier leakage
- Summary
- Blood-brain barrier repair
- Blood-brain barrier repair - combination therapy
- Thank you
Topics Covered
- The blood-brain barrier
- Alzheimer’s disease
- The blood-brain barrier in Alzheimer’s disease
- Cerebral blood flow
- Glucose transport
- Aβ clearance
- Blood-brain barrier leakage
- Blood-brain barrier repair
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Hartz, A. (2021, June 28). The blood-brain barrier in Alzheimer’s disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/UVSZ2452.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
A selection of talks on Neurology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Anika Hartz.
I'm Associate Professor at the Sanders-Brown Center on Aging,
Department of Pharmacology and Nutritional Sciences
at the University of Kentucky in Lexington, Kentucky.
This presentation focuses on the blood-brain barrier in Alzheimer's disease.
0:20
I will first give an introduction on the blood-brain barrier,
how it was discovered,
a little bit on the anatomy and barrier function.
Then I will give an overview on Alzheimer's disease,
how the disease was discovered,
some numbers and facts,
disease pathology, prognosis and treatment,
and I will then talk about how the blood-brain barrier changes in Alzheimer's disease.
There we will touch upon cerebral blood flow,
glucose transport across the blood-brain barrier,
A-Beta clearance and blood-brain barrier leakage.
The last section, I will highlight
some recent approaches on how to achieve blood-brain barrier repair.
Then I will end the presentation with a summary.
1:06
Let's get started with the blood-brain barrier and how it was discovered.
1:13
Paul Ehrlich, a German microbiologist at
the Charite in Berlin discovered the blood-brain barrier by pure chance.
Ehrlich initial intent was to determine the oxygen demands of the body.
In his experiments, Ehrlich injected rodents intravenously with so-called wild dyes,
and observed that all organs were stained with the dyes,
except for the brain and the spinal cord.
Several years later in 1913
Edwin Goldman, Ehrlich graduate student repeated the original studies
and observed that injecting trypan blue
intrathecally stains the brain parenchyma and spinal cord.
Various organs were not.
The opposite effect compared to intravenous dye injection.
This finding confirmed Goldman's hypothesis
that there is a barrier between the central nervous system and the periphery,
and provided further evidence for the existence of
compartments and the barrier between the brain and the periphery.
In 1908, Paul Ehrlich was awarded a Nobel Prize in recognition of his work on immunity.
However, in the blood-brain barrier research field,
Paul Ehrlich is celebrated as the father of the barrier,
but he himself never quite believed in the barrier.
Today, Ehrlich and Goldman's experiments are
considered the beginning of blood-brain barrier research.
However, the term blood-brain barrier was not introduced until
1921 by the Russian physiologist Denas Dan.